Company Filing History:
2 out of 1,536 
1 out of 194 
Years Active: 2009-2013
Title: The Innovative Contributions of Matthias Hoffman
Introduction
Matthias Hoffman, an accomplished inventor based in Mittelbiberach, Germany, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, his work primarily focuses on developing innovative compounds that address various medical conditions.
Latest Patents
Hoffman's latest patents include noteworthy advancements such as "Pteridinone derivatives as PI3-kinases inhibitors". This patent involves new compounds that exhibit pharmaceutical activity as PI3-kinase modulators, which can be utilized in treating inflammatory or allergic diseases. The particular conditions targeted by these compounds range from respiratory complaints and gastrointestinal inflammatory diseases to skin and eye diseases, as well as autoimmune reactions affecting the kidneys.
Another significant patent is for "Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositions and processes of making the same." This patent discloses dihydropteridinones of general formula (I), which have medicinal uses in treating or preventing cancer, infections, and inflammatory or autoimmune diseases.
Career Highlights
Hoffman's career has been marked by various roles in prominent pharmaceutical companies, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. His experience and expertise in the field have allowed him to contribute to cutting-edge research and development efforts within these organizations.
Collaborations
Throughout his career, Matthias Hoffman has collaborated with other talented professionals, including Matthias Grauert and Trixi Brandl. These partnerships have further enhanced his research capabilities and broadened the scope of his innovative contributions.
Conclusion
Matthias Hoffman is a notable figure in the realm of pharmaceutical innovation, with multiple patents showcasing his dedication to developing novel compounds aimed at improving human health. His ongoing work signifies the importance of research and collaboration in creating solutions for complex medical challenges.